These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 670384)

  • 41. [Distribution of aminoside resistance in 430 strains of gram-negative bacilli in a hospital environment. Value of amikacine].
    Le Noc P; Croizé J
    Sem Hop Ther; 1977; 53(7-8):378-83. PubMed ID: 244369
    [No Abstract]   [Full Text] [Related]  

  • 42. A classification of microorganisms frequently causing sepsis.
    Brown WJ
    Heart Lung; 1976; 5(3):397-405. PubMed ID: 1046047
    [No Abstract]   [Full Text] [Related]  

  • 43. [Some clinical, physiopathological and therapeutic aspects of gram-negative septicemia].
    Smith-Erichsen N; Aasen AO
    Tidsskr Nor Laegeforen; 1981 Oct; 101(30):1690-2. PubMed ID: 7339954
    [No Abstract]   [Full Text] [Related]  

  • 44. Characterization and anti-microbial susceptibility of bacterial isolates: Experience from a tertiary care cancer center in Delhi.
    Singh R; Jain S; Chabbra R; Naithani R; Upadhyay A; Walia M
    Indian J Cancer; 2014; 51(4):477-80. PubMed ID: 26842169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nosocomial bloodstream infections caused by gentamicin-resistant gram-negative bacilli.
    Guerrant RL; Strausbaugh LJ; Wenzel RP; Hamory BH; Sande MA
    Am J Med; 1977 Jun; 62(6):894-901. PubMed ID: 868904
    [No Abstract]   [Full Text] [Related]  

  • 46. Loss of antimicrobial susceptibility in aerobic gram-negative bacilli repeatedly isolated from patients in intensive-care units.
    Manian FA; Meyer L; Jenne J; Owen A; Taff T
    Infect Control Hosp Epidemiol; 1996 Apr; 17(4):222-6. PubMed ID: 8935729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New species-related MIC breakpoints for early detection of development of resistance among gram-negative bacteria in Swedish intensive care units.
    Hanberger H; Nilsson LE; Claesson B; Kärnell A; Larsson P; Rylander M; Svensson E; Sörberg M; Sörén L
    J Antimicrob Chemother; 1999 Nov; 44(5):611-9. PubMed ID: 10552977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals.
    Duncan IB; Cheung EY; Haldane EV; Jackson FL; McNaughton RD; Morisset RA; Noble MA; Rennie RP; Ronald AR; Smith JA
    Can Med Assoc J; 1981 May; 124(9):1165-7. PubMed ID: 7237336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibacterial activity of Ro 17-2301 and other antimicrobial agents against cefotaxime-resistant aerobic gram-negative bacilli.
    Benson CA; Walton FE; Trenholme GM
    Antimicrob Agents Chemother; 1986 Jan; 29(1):155-7. PubMed ID: 3079583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Susceptibility survey of piperacillin/tazobactam and some beta-lactam comparators in Italy.
    Stefani S; Bonfiglio G; Bianchi C; Zollo A; Nicoletti G
    Drugs Exp Clin Res; 1998; 24(2):105-13. PubMed ID: 9675551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli from patients with intra-abdominal infections worldwide from 2005-2007: results from the SMART study.
    Hawser SP; Bouchillon SK; Hoban DJ; Badal RE
    Int J Antimicrob Agents; 2009 Dec; 34(6):585-8. PubMed ID: 19748234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparative in vitro activity of cefepime and other antibiotics against clinical strains of gram-negative bacteria].
    Beloborodova NV; Vostrikova TIu; Mel'ko AI
    Antibiot Khimioter; 2003; 48(7):12-5. PubMed ID: 14628572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro evaluation of actinobolin as an antibiotic for the treatment of periodontal disease.
    Armstrong PJ; Hunt DE
    Appl Microbiol; 1972 Jan; 23(1):88-90. PubMed ID: 5059624
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents. Special references to bacteria isolated between July 1995 and June 1996].
    Shinagawa N; Koide H; Hirata K; Denno R; Mukaiya M; Ishibiki K; Ushijima Y; Aikawa N; Takuma K; Iwai S; Kunimatsu M; Ohtsuka K; Yura J; Manabe T; Mashita K; Ishikawa S; Mizuno A; Kinoshita H; Morimoto K; Fujimoto M; Tanimura H; Ohnishi H; Sakaguchi S; Dounishi H; Oda S
    Jpn J Antibiot; 1997 Feb; 50(2):143-77. PubMed ID: 9100076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups.
    Hanberger H; Garcia-Rodriguez JA; Gobernado M; Goossens H; Nilsson LE; Struelens MJ
    JAMA; 1999 Jan; 281(1):67-71. PubMed ID: 9892453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [In vitro activity of seven gyrase inhibitors of a group of heterocyclic carbonic acids against nonfermenting gram negative rods (nonfermenters)].
    Grimm H
    Arzneimittelforschung; 1985; 35(3):570-2. PubMed ID: 2986655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Occurence and identification of Gram-negative non-fermenting bacteria in urine (author's transl)].
    Rusínko M; Kohút P
    Cesk Epidemiol Mikrobiol Imunol; 1977 May; 26(3):129-34. PubMed ID: 144023
    [No Abstract]   [Full Text] [Related]  

  • 58. An observational study on the epidemiology of respiratory tract bacterial pathogens and their susceptibility to four injectable beta-lactam antibiotics: piperacillin, piperacillin/tazobactam, ceftazidime and ceftriaxone.
    Varotto F; Maria GD; Azzaro R; Bellissima P; Amato R; Fogliani V; Muscianisi G; Vitale S; Girbino G; Andò F; Laganà P; Delia S; Jacoviello C; Maierna G; Pezza A; Covelli I; Magrì M; Napoletano G; Rossi A; Marone P; Sanguinetti C; Pela R; Tedeschi D; Viola B; Cicciarella S; Messina G; Rizza S; Fraschini F
    J Chemother; 2001 Aug; 13(4):413-23. PubMed ID: 11589485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Septicemia with gram-negative bacilli. The possibilities and limits of an etiological therapy].
    Grigore L
    Bacteriol Virusol Parazitol Epidemiol; 1996; 41(3-4):151-60. PubMed ID: 9116405
    [No Abstract]   [Full Text] [Related]  

  • 60. [Septicemia causative organisms 1983-1985. The results of a multicenter study].
    Rosenthal EJ
    Dtsch Med Wochenschr; 1986 Dec; 111(49):1874-80. PubMed ID: 3780463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.